Analyst Ratings for Soleno Therapeutics Inc. (SLNO)
SLNO Rating Summary
SLNO Price Target Summary
- Highest: $125.00 (Goldman Sachs)
- Lowest: $53.00 (Stifel)
- Average: $70.86
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$70.86 (+33.7%)
* Over Last 12-Mos
Rating Score: 2.9 / 10
Percentile Rank: 24%
Avg. $ Target:
$70.86 (+33.7%)
* Over Last 12-Mos
Rating Score: 2.9 / 10
Percentile Rank: 24%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/17/2026 | Wells Fargo | Derek Archila | Downgrade | Equal Weight (Overweight) |
53.00 (110.00) |
52.57 (53.01) |
0.84% | Details |
| 4/8/2026 | H.C. Wainwright | Raghuram Selvaraju | Downgrade | Neutral (Buy) |
N/A (N/A) |
52.35 (53.01) |
1.26% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
